Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 274, Issue 6 37-6, 1998, Pages

  Sawaoka, Hitoshi ^a   Kawano, Sunao ^a   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Gunawan, Edhi S ^a   Takei, Yoshiyuki ^a   Nagano, Kouichi ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cell proliferation; Nonsteroidal anti inflammatory drugs; Programmed cell death; Prostaglandin

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIVISION; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; STOMACH CANCER; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0031799475     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.274.6.g1061     Document Type: Article

References (35)

1. Bursh, W., L. Kleine, and M. Tenniswood. The biochemistry of cell death by apoptosis. Biochem. Cell Biol. 68: 1071-1074, 1990.
2. Bursh, W., S. Paffe, B. Putz, G. Barthel, and R. Sculte-Hermann. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11: 847-853, 1990.
3. DuBois, R. N., J. Awad, J. Morrow, L. J. Roberts II, and P. R. Bishop. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J. Clin. Invest. 93: 493-498, 1994.
4. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 56: 733-737, 1996.
5. DuBois, R. N., M. Tsujii, P. Biship, J. A. Awad, K. Makita, and A. Lanahan. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G822-G827, 1994.
6. Eberhart, C. E., R. J. Coffey, A. Radhika, F. M. Giardiello, S. Ferrenbach, and R. N. DuBois. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
7. Futaki, N., I. Arai, Y. Hamasaka, S. Takahashi, S. Higuchi, and S. Otomo. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45: 753-755, 1993.
8. Futaki, N., K. Yoshikawa, Y. Hamasaka, I. Arai, S. Higuchi, H. Iizuka, and S. Otomo. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24: 105-110, 1993.
9. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501, 1992.
10. Gierse, J. K., S. D. Hauser, D. P. Creely, C. Koboldt, S. H. Rangwala, P. C. Isakson, and K. Seibert. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305: 479-484, 1995.
11. Gold, R. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71: 219-225, 1994.
12. Houchens, D. P., A. A. Ovejera, and A. D. Barker. The treatment of human tumors in athymic (nude) mice. In: Proceedings of the Symposium on the Use of Athymic (Nude) Mice in Cancer Research, edited by D. P. Houchens and A. A. Ovejera. New York: Gustav Fischer, 1978, p. 267-280.
13. Kelsen, D. P. Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol. 23: 379-387, 1996.
14. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
15. Masferrer, J. L., B. S. Zweifel, P. T. Manning, S. D. Hauser, K. M. Leahy, W. G. Smith, P. C. Isakson, and K. Seibert. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91: 3228-3232, 1994.
16. Metzger, U., J. Meier, G. Uhlschmidt, and H. Weihe. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis. Colon Rectum 27: 366-369, 1984.
17. Motoyama, T., H. Hojo, and H. Watanabe. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn. 36: 65-83, 1986.
18. Narisawa, T., M. Sato, M. Tani, T. Kudo, T. Takahashi, and A. Goto. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 41: 1954-1957, 1981.
19. Nugent, K. P., K. C. Farmer, A. D. Spiegelman, C. B. Williams, and R. K. Phillips. Randomized double blind placebo controlled clinical trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in familial adenomatous polyposis. Br. J. Surg. 80: 1618-1619, 1993.
20. Nygard, G., A. Anthony, C. Piasecki, M. A. Trevethick, M. Hudson, A. P. Dhillon, R. E. Pounder, and A. J. Wakefield. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 106: 567-575, 1994.
21. Polland, M., and P. H. Luckert. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat. Rev. 64: 1323-1327, 1980.
22. Reddy, B. S., H. Murayama, and G. Kelloff. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res. 47: 5340-5346, 1987.
23. Ristimäki, A., N. Honkanen, H. Jänkälä, P. Sipponen, and M. Härkönen. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57: 1276-1280, 1997.
24. Rosenberg, L., J. R. Palmer, A. G. Zauber, M. E. Warshauer, P. D. Stolley, and S. Shapiro. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst. 83: 355-358, 1991.
25. Sato, H., I. Inada, T. Hirata, and Y. Maki. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 81: 719-725, 1981.
26. Sheng, H., J. Shao, S. C. Kirkland, P. Isakson, R. J. Coffey, J. Morrow, R. D. Beauchamp, and R. N. DuBois. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99: 2254-2259, 1997.
27. Shiff, S. J., M. I. Koutsos, L. Qiao, and B. Rigas. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res. 222: 179-188, 1996.
28. Shiu, M. H., M. Perrotti, and M. F. Brennan. Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology 36: 7-12, 1989.
29. Statistics, Bureau Management, and Coordination Agency. Japan Statistical Yearbook 1997. Tokyo: Government of Japan, 1997.
30. Takei, Y., I. Marzi, F. C. Kauffman, R. T. Currin, J. J. Lemasters, and R. G. Thurman. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 50: 14-20, 1990.
31. Thun, M. J., M. M. Namboodiri, and C. W. J. Heath. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325: 1593-1596, 1991.
32. Tsuji, S., S. Kawano, H. Sawaoka, Y. Takei, I. Kobayashi, K. Nagano, H. Fusamoto, and T. Kamada. Evidence for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot. Essent. Fatty Acids 55: 179-183, 1996.
33. Tsujii, M., and R. N. DuBois. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
34. Wanebo, H. J., B. J. Kennedy, J. Chemiel, G. Steele, Jr., D. Winchester, and R. Osteen. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann. Surg. 218: 583-592, 1993.
35. World Health Organization. World Health Statistics Annual 1994. Geneva: World Health Organization, 1995.